This NDC is on FDA's drug shortage list (posted Apr 7, 2020)
Reported reason: Demand increase for the drug
Product Information
FUROSEMIDE 20 MG/2 ML VIAL is a generic product labeled by Eugia US LLC, priced at $0.4901 per ML under NDC 55150032225. Its NADAC has been published 129 times since Apr 17, 2024.
FDA first approved this application on May 3, 2019. Its Orange Book therapeutic-equivalence code is AP.
Strength
20 mg/2mL
Manufacturer
Eugia US LLCNDC
55150032225
Classification
Generic
Dosage Form
INJECTION, SOLUTION
Route
INTRAMUSCULAR; INTRAVENOUS
Effective Date
9/23/2026
Active Ingredients
FUROSEMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA212174FDA Approved
5/3/2019
TE Code
AP
On Market Since
5/3/2019
Pharmacological Classes
Price Statistics
The NADAC for FUROSEMIDE 20 MG/2 ML VIAL has been published 129 times since Apr 17, 2024, and over the history we have for it it has declined 21.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.4901 per ML |
|---|---|
| All-time high | $0.6277 (May 15, 2024) |
| All-time low | $0.3473 (Dec 17, 2025) |
| 52-week high | $0.4901 |
| 52-week low | $0.3473 |
| Median price | $0.4073 |
| Average price | $0.4375 |
| Largest weekly change | -22.5% (Dec 18, 2024) |
| Weeks tracked | 129 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Furosemide market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Eugia US LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Furosemide market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Loop Diuretic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FUROSEMIDE 20 MG/2 ML VIAL?
The current National Average Drug Acquisition Cost (NADAC) for FUROSEMIDE 20 MG/2 ML VIAL, manufactured by Eugia US LLC, is $0.4901 per ML (NDC 55150032225), effective Sep 30, 2026.
How has the price of FUROSEMIDE 20 MG/2 ML VIAL changed over time?
Over the history we have for it, the NADAC for FUROSEMIDE 20 MG/2 ML VIAL has declined 21.9%. It has been tracked across 129 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for FUROSEMIDE 20 MG/2 ML VIAL?
Since Apr 17, 2024, the NADAC for FUROSEMIDE 20 MG/2 ML VIAL has ranged from a low of $0.3473 (Dec 17, 2025) to a high of $0.6277 (May 15, 2024), with a median of $0.4073 per ML.
Are there cheaper alternatives to FUROSEMIDE 20 MG/2 ML VIAL?
No other NADAC-published product currently shares the active ingredient and strength of FUROSEMIDE 20 MG/2 ML VIAL in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures FUROSEMIDE 20 MG/2 ML VIAL?
FUROSEMIDE 20 MG/2 ML VIAL (NDC 55150032225) is labeled by Eugia US LLC, and CMS classifies it as a generic product.
Is FUROSEMIDE 20 MG/2 ML VIAL in shortage?
Yes — NDC 55150032225 is currently listed in FDA's drug shortage database (posted Apr 7, 2020). Reported reason: Demand increase for the drug.